ID   ABHD2_HUMAN             Reviewed;         425 AA.
AC   P08910; Q53G48; Q53GU0; Q5FVD9; Q8TC79;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   28-JUN-2023, entry version 181.
DE   RecName: Full=Monoacylglycerol lipase ABHD2 {ECO:0000305};
DE            EC=3.1.1.23 {ECO:0000269|PubMed:26989199};
DE   AltName: Full=2-arachidonoylglycerol hydrolase {ECO:0000305};
DE   AltName: Full=Abhydrolase domain-containing protein 2 {ECO:0000305};
DE   AltName: Full=Acetylesterase {ECO:0000305};
DE            EC=3.1.1.6 {ECO:0000269|PubMed:27247428};
DE   AltName: Full=Lung alpha/beta hydrolase 2 {ECO:0000250|UniProtKB:Q9QXM0};
DE   AltName: Full=Progesterone-sensitive lipase {ECO:0000305};
DE            EC=3.1.1.79 {ECO:0000269|PubMed:27247428};
DE   AltName: Full=Protein PHPS1-2 {ECO:0000303|PubMed:2843827};
GN   Name=ABHD2 {ECO:0000312|HGNC:HGNC:18717};
GN   Synonyms=LABH2 {ECO:0000250|UniProtKB:Q9QXM0};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2843827; DOI=10.1093/nar/16.17.8721;
RA   Rapiejko P.J., George S.T., Malbon C.C.;
RT   "Primary structure of a human protein which bears structural similarities
RT   to members of the rhodopsin/beta-adrenergic receptor family.";
RL   Nucleic Acids Res. 16:8721-8721(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Utleg A., White J., Lin B.;
RT   "Cloning of an androgen-regulated a/b hydrolase.";
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Gastric carcinoma, and Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-253.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
RX   PubMed=27247428; DOI=10.1042/bsr20160033;
RA   M N.K., V B S C T., G K V., B C.S., Guntupalli S., J S B.;
RT   "Molecular characterization of human ABHD2 as TAG lipase and ester
RT   hydrolase.";
RL   Biosci. Rep. 36:0-0(2016).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=26989199; DOI=10.1126/science.aad6887;
RA   Miller M.R., Mannowetz N., Iavarone A.T., Safavi R., Gracheva E.O.,
RA   Smith J.F., Hill R.Z., Bautista D.M., Kirichok Y., Lishko P.V.;
RT   "Unconventional endocannabinoid signaling governs sperm activation via sex
RT   hormone progesterone.";
RL   Science 352:555-559(2016).
CC   -!- FUNCTION: Progesterone-dependent acylglycerol lipase that catalyzes
CC       hydrolysis of endocannabinoid arachidonoylglycerol (AG) from cell
CC       membrane (PubMed:26989199). Acts as a progesterone receptor:
CC       progesterone-binding activates the acylglycerol lipase activity,
CC       mediating degradation of 1-arachidonoylglycerol (1AG) and 2-
CC       arachidonoylglycerol (2AG) to glycerol and arachidonic acid (AA)
CC       (PubMed:26989199). Also displays an ester hydrolase activity against
CC       acetyl ester, butanoate ester and hexadecanoate ester
CC       (PubMed:27247428). Plays a key role in sperm capacitation in response
CC       to progesterone by mediating degradation of 2AG, an inhibitor of the
CC       sperm calcium channel CatSper, leading to calcium influx via CatSper
CC       and sperm activation (PubMed:26989199). May also play a role in smooth
CC       muscle cells migration (By similarity). {ECO:0000250|UniProtKB:Q9QXM0,
CC       ECO:0000269|PubMed:26989199, ECO:0000269|PubMed:27247428}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an acetyl ester + H2O = acetate + an aliphatic alcohol + H(+);
CC         Xref=Rhea:RHEA:12957, ChEBI:CHEBI:2571, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30089, ChEBI:CHEBI:47622; EC=3.1.1.6;
CC         Evidence={ECO:0000269|PubMed:27247428};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12958;
CC         Evidence={ECO:0000305|PubMed:27247428};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolyzes glycerol monoesters of long-chain fatty acids.;
CC         EC=3.1.1.23; Evidence={ECO:0000269|PubMed:26989199};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.79;
CC         Evidence={ECO:0000269|PubMed:27247428};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000305|PubMed:27247428};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H2O =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoate + glycerol + H(+);
CC         Xref=Rhea:RHEA:26132, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17754, ChEBI:CHEBI:32395, ChEBI:CHEBI:52392;
CC         Evidence={ECO:0000269|PubMed:26989199};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:26133;
CC         Evidence={ECO:0000305|PubMed:26989199};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a butanoate ester + H2O = an aliphatic alcohol + butanoate +
CC         H(+); Xref=Rhea:RHEA:47348, ChEBI:CHEBI:2571, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17968, ChEBI:CHEBI:50477;
CC         Evidence={ECO:0000269|PubMed:27247428};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47349;
CC         Evidence={ECO:0000305|PubMed:27247428};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hexadecanoate ester = an aliphatic alcohol + H(+) +
CC         hexadecanoate; Xref=Rhea:RHEA:47392, ChEBI:CHEBI:2571,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:25835; Evidence={ECO:0000269|PubMed:27247428};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47393;
CC         Evidence={ECO:0000305|PubMed:27247428};
CC   -!- ACTIVITY REGULATION: Acylglycerol lipase activity is activated upon
CC       binding to progesterone. {ECO:0000269|PubMed:26989199}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.4 mM for p-nitrophenyl acetate {ECO:0000269|PubMed:27247428};
CC         KM=11.76 mM for p-nitrophenyl butyrate {ECO:0000269|PubMed:27247428};
CC         KM=17.66 mM for p-nitrophenyl palmitate
CC         {ECO:0000269|PubMed:27247428};
CC         Vmax=2.69 umol/sec/mg enzyme toward p-nitrophenyl acetate
CC         {ECO:0000269|PubMed:27247428};
CC         Vmax=3.71 umol/sec/mg enzyme toward p-nitrophenyl butyrate
CC         {ECO:0000269|PubMed:27247428};
CC         Vmax=1.27 umol/sec/mg enzyme toward p-nitrophenyl palmitate
CC         {ECO:0000269|PubMed:27247428};
CC       pH dependence:
CC         Optimum pH is 8.5 for p-nitrophenyl palmitate and 7.5 for
CC         p-nitrophenyl acetate and p-nitrophenyl butyrate.
CC         {ECO:0000269|PubMed:27247428};
CC       Temperature dependence:
CC         Optimum temperature is 45 degrees Celsius with p-nitrophenyl
CC         palmitate and 30 degrees Celsius with p-nitrophenyl acetate and
CC         p-nitrophenyl butyrate. {ECO:0000269|PubMed:27247428};
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum membrane
CC       {ECO:0000305|PubMed:26989199}; Single-pass type II membrane protein
CC       {ECO:0000305}. Cell membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Present in sperm (at protein level).
CC       {ECO:0000269|PubMed:26989199}.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. AB hydrolase 4
CC       family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a G-coupled receptor.
CC       {ECO:0000305|PubMed:2843827}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X12433; CAA30976.1; -; mRNA.
DR   EMBL; AF546700; AAQ12021.1; -; mRNA.
DR   EMBL; AK222841; BAD96561.1; -; mRNA.
DR   EMBL; AK223083; BAD96803.1; -; mRNA.
DR   EMBL; BC019248; AAH19248.1; -; mRNA.
DR   EMBL; BC090052; AAH90052.1; -; mRNA.
DR   CCDS; CCDS10348.1; -.
DR   PIR; A31026; A31026.
DR   RefSeq; NP_008942.3; NM_007011.7.
DR   RefSeq; NP_690888.1; NM_152924.4.
DR   RefSeq; XP_005254889.1; XM_005254832.1.
DR   RefSeq; XP_005254890.1; XM_005254833.1.
DR   RefSeq; XP_011519467.1; XM_011521165.1.
DR   AlphaFoldDB; P08910; -.
DR   BioGRID; 116242; 10.
DR   STRING; 9606.ENSP00000268129; -.
DR   SwissLipids; SLP:000001546; -.
DR   ESTHER; human-ABHD2; abh_upf0017.
DR   GlyCosmos; P08910; 1 site, No reported glycans.
DR   GlyGen; P08910; 1 site.
DR   iPTMnet; P08910; -.
DR   PhosphoSitePlus; P08910; -.
DR   SwissPalm; P08910; -.
DR   BioMuta; ABHD2; -.
DR   DMDM; 123504; -.
DR   MassIVE; P08910; -.
DR   MaxQB; P08910; -.
DR   PaxDb; P08910; -.
DR   PeptideAtlas; P08910; -.
DR   ProteomicsDB; 52174; -.
DR   Antibodypedia; 1104; 183 antibodies from 26 providers.
DR   DNASU; 11057; -.
DR   Ensembl; ENST00000352732.10; ENSP00000268129.5; ENSG00000140526.18.
DR   Ensembl; ENST00000565973.5; ENSP00000455639.1; ENSG00000140526.18.
DR   GeneID; 11057; -.
DR   KEGG; hsa:11057; -.
DR   MANE-Select; ENST00000352732.10; ENSP00000268129.5; NM_152924.5; NP_690888.1.
DR   UCSC; uc002bnk.2; human.
DR   AGR; HGNC:18717; -.
DR   CTD; 11057; -.
DR   DisGeNET; 11057; -.
DR   GeneCards; ABHD2; -.
DR   HGNC; HGNC:18717; ABHD2.
DR   HPA; ENSG00000140526; Low tissue specificity.
DR   MIM; 612196; gene.
DR   neXtProt; NX_P08910; -.
DR   OpenTargets; ENSG00000140526; -.
DR   PharmGKB; PA38658; -.
DR   VEuPathDB; HostDB:ENSG00000140526; -.
DR   eggNOG; KOG1838; Eukaryota.
DR   GeneTree; ENSGT00950000182902; -.
DR   HOGENOM; CLU_032487_5_0_1; -.
DR   InParanoid; P08910; -.
DR   OMA; DHCRRFY; -.
DR   OrthoDB; 4242155at2759; -.
DR   PhylomeDB; P08910; -.
DR   TreeFam; TF313195; -.
DR   PathwayCommons; P08910; -.
DR   SignaLink; P08910; -.
DR   BioGRID-ORCS; 11057; 9 hits in 1154 CRISPR screens.
DR   ChiTaRS; ABHD2; human.
DR   GeneWiki; ABHD2; -.
DR   GenomeRNAi; 11057; -.
DR   Pharos; P08910; Tbio.
DR   PRO; PR:P08910; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P08910; protein.
DR   Bgee; ENSG00000140526; Expressed in corpus epididymis and 197 other tissues.
DR   ExpressionAtlas; P08910; baseline and differential.
DR   Genevisible; P08910; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0036126; C:sperm flagellum; IDA:UniProtKB.
DR   GO; GO:0097524; C:sperm plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008126; F:acetylesterase activity; IDA:UniProtKB.
DR   GO; GO:0047372; F:acylglycerol lipase activity; IDA:UniProtKB.
DR   GO; GO:0042562; F:hormone binding; IDA:UniProtKB.
DR   GO; GO:0033878; F:hormone-sensitive lipase activity; IDA:UniProtKB.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; IDA:UniProtKB.
DR   GO; GO:0004806; F:triglyceride lipase activity; IEA:RHEA.
DR   GO; GO:0007340; P:acrosome reaction; IEA:Ensembl.
DR   GO; GO:0046464; P:acylglycerol catabolic process; IDA:UniProtKB.
DR   GO; GO:0051792; P:medium-chain fatty acid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0051793; P:medium-chain fatty acid catabolic process; IBA:GO_Central.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IDA:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0014909; P:smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0048240; P:sperm capacitation; IDA:UniProtKB.
DR   GO; GO:0043401; P:steroid hormone mediated signaling pathway; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   InterPro; IPR000952; AB_hydrolase_4_CS.
DR   InterPro; IPR012020; ABHD4.
DR   PANTHER; PTHR10794; ABHYDROLASE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR10794:SF45; MONOACYLGLYCEROL LIPASE ABHD2; 1.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   PIRSF; PIRSF005211; Ab_hydro_YheT; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS01133; UPF0017; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Cilium; Flagellum; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Reference proteome;
KW   Serine esterase; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..425
FT                   /note="Monoacylglycerol lipase ABHD2"
FT                   /id="PRO_0000212457"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        10..30
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        31..425
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          128..382
FT                   /note="AB hydrolase-1"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        207
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WA6"
FT   ACT_SITE        345
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WA6"
FT   ACT_SITE        376
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q86WA6"
FT   CARBOHYD        136
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   VARIANT         253
FT                   /note="R -> Q (in dbSNP:rs17851730)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031203"
FT   CONFLICT        27
FT                   /note="Y -> C (in Ref. 3; BAD96803)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="E -> G (in Ref. 3; BAD96561)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   425 AA;  48315 MW;  747C6AB2C99B3CC2 CRC64;
     MNAMLETPEL PAVFDGVKLA AVAAVLYVIV RCLNLKSPTA PPDLYFQDSG LSRFLLKSCP
     LLTKEYIPPL IWGKSGHIQT ALYGKMGRVR SPHPYGHRKF ITMSDGATST FDLFEPLAEH
     CVGDDITMVI CPGIANHSEK QYIRTFVDYA QKNGYRCAVL NHLGALPNIE LTSPRMFTYG
     CTWEFGAMVN YIKKTYPLTQ LVVVGFSLGG NIVCKYLGET QANQEKVLCC VSVCQGYSAL
     RAQETFMQWD QCRRFYNFLM ADNMKKIILS HRQALFGDHV KKPQSLEDTD LSRLYTATSL
     MQIDDNVMRK FHGYNSLKEY YEEESCMRYL HRIYVPLMLV NAADDPLVHE SLLTIPKSLS
     EKRENVMFVL PLHGGHLGFF EGSVLFPEPL TWMDKLVVEY ANAICQWERN KLQCSDTEQV
     EADLE
//
